The EHRA Antiarrhythmic Drug Compendium is now published in full
A practical, comprehensive resource for the safe and effective use of AADs in daily practice.
@Cait_Centra When AFIRE was first published in ‘19, had much more reluctance from many of our providers. Over the last few years, we’ve seen much more acceptance for OAC monotherapy.
Happy to share MDCalc is now hosting the DOAC Score
Last year we published a calculator that predicts bleeding among AFib patients. It outperformed HAS-BLED in 4 multinational cohorts
An international collaboration w/ @SmithBIDMC@TIMIStudyGroup@rwyeh
https://t.co/2DDeRsWZsQ
📆 Save the Date 📆
9/10/24 - 1:00-2:00 pm EDT
Managing the Failing Heart in the ICU: Tips and Tricks for Kick Starting the Heart
💊 Joint ACCP CC and Cards PRN Webinar Program
📖 1hr ACPE CE credits
🖥️ Registration Link: https://t.co/zTDQErtYdh
#PharmICU#critPRN
It's #TeachingTuesday! @SLPharmacy PGY2 Cardiology Resident @HarleyNMoore is teaching us about colchicine use for secondary prevention of cardiovascular disease! Is colchicine part of your medical therapy for patients with recurrent ASCVD events? 🫀
#TeachingTuesday is back next week with @SLPharmacy PGY2 Cardiology Resident @HarleyNMoore! Learn more about a controversial medication in coronary artery disease 🫀
It’s #WhatsNewWednesday! @HyperAHA article reviews practical steps to manage orthostatic hypotension...including this figure stratifying OH risk of BP meds.
Check it out 👇
https://t.co/e6zQ8h0CRl
🚨NEW POD ALERT🚨
Trial of the Week: CHAMPION PHOENIX
Ft. Jack Pluenneke @JackPluenneke
CHAMPION trilogy 🥉
Comparator group using clopidogrel? 😵💫
Cangrelor v. GPIs ⚔️
IV to PO P2Y12 transition 💊
PCI v. Bridge dosing 🌉
Cangrelor’s place in therapy 📜
& much, more!
https://t.co/UoGK2GRBnF
https://t.co/jvJE8QLEhB
https://t.co/7Ny2zpv0ZE
#pharmicu #twitterx #cardiotwitter #cangrelor #stemi #foamed #foamcc #meded #some